Showing results (101-110 of 496) with videos related to

Sort By:
Pageof 50
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Rapid Decline of Mpox Antibody Responses Following MVA-BN VaccinationAi-Ris Y Collier, Katherine McMahan, Catherine Jacob-Dolan, et al.
Pathogens (Basel, Switzerland)|November 6, 2019
Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as CarriersCésar López-Camacho, Young Chan Kim, Peter Abbink, et al.
Clinical and Vaccine Immunology : CVI|June 20, 2014
Hexon hypervariable region-modified adenovirus type 5 (Ad5) vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectorsJeffrey E Teigler, Pablo Penaloza-MacMaster, Rebecca Obeng, et al.
Journal of Virology|February 8, 2013
An attenuated Listeria monocytogenes vector primes more potent simian immunodeficiency virus-specific mucosal immunity than DNA vaccines in miceEung-Jun Im, Erica N Borducchi, Nicholas M Provine, et al.
Journal of Virology|March 23, 2018
Immunogenicity and Cross-Reactivity of Rhesus Adenoviral VectorsM Justin Iampietro, Rafael A Larocca, Nicholas M Provine, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2021
Adenovirus-vectored vaccine containing multidimensionally conserved parts of the HIV proteome is immunogenic in rhesus macaquesDariusz K Murakowski, John P Barton, Lauren Peter, et al.
Iscience|September 3, 2024
Compartment-specific antibody correlates of protection to SARS-CoV-2 Omicron in macaquesXin Tong, Qixin Wang, Wonyeong Jung, et al.
Journal of Immunological Methods|December 3, 2014
Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine developmentKathryn E Stephenson, George H Neubauer, Ulf Reimer, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Compartment-Specific Antibody Correlates of Protection to SARS-CoV-2 Omicron in MacaquesXin Tong, Qixin Wang, Wonyeong Jung, et al.
The Lancet. HIV|October 6, 2023
Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trialMagdalena E Sobieszczyk, Sharon Mannheimer, Carmen A Paez, et al.
Pageof 50